Register | Forgot password?
Switch to Arabic
Wednesday, February 10 - 2010
Page navigation Browse related articles

Study in UAE shows yoga an effective treatment for rheumatoid arthritis

  • United Arab Emirates: Thursday, September 25 - 2008 at 09:21
  • PRESS RELEASE

A pilot study conducted in the UAE reveals 12 sessions of yoga significantly improved the conditions of rheumatoid arthritis (RA) patients.

Article continues below
  • Dr. Badsha, specialist rheumatologist, Dubai Bone and Joint Center (DBAJ).
    Dr. Badsha, specialist rheumatologist, Dubai Bone and Joint Center (DBAJ).
This study was presented before the 13th Congress of the Asia Pacific League of Associations for Rheumatology in Yokohama, Japan by a team of Specialists in the United Arab Emirates.

Dr. Badsha, specialist rheumatologist, Dubai Bone and Joint Center (DBAJ), declared:
"It is possible that yoga may have important physical and psychological benefits for patients with rheumatoid arthritis."


A total of 47 patients were enrolled, of which 26 undertook yoga sessions, while 21 were on regular arthritis treatment. The baseline demographics were similar in both groups. The Raj yoga sessions were conducted by a licensed practitioner with a Master's qualification in Yoga. Raj yoga is defined as "concerned principally with the cultivation of the mind using meditation to further one's acquaintance with reality and finally achieve liberation.". The yoga was specially modified to suit arthritis patients by Dr. Vishwas Chhabra and Dr. Badsha, and this new program is being called Vishwas Yoga for Arthritis.

The study was funded by the Emirates Arthritis Foundation which has taken a lead role in the education and well being of arthritis patients in the UAE, since its launch in 2006.

"Our study was able to demonstrate statistically significant improvements in RA disease parameters and especially Health Assessment Questionnaire scores. Some patients in the yoga group were able to decrease or discontinue RA medications. We believe that a longer duration of treatment could result in more significant improvements," explained Dr. Badsha.

According to the study, three patients discontinued steroids, one discontinued Etarnecept, and two discontinued Methotrexate, all because of clinical improvements. The 47 patients were age over 18 years and were diagnosed with RA according to American College of Rheumatology criteria.

Dr. Badsha has been the principal investigator in various clinical trials of medications for RA in the UAE. She has conducted various research studies on Lupus and Autoimmune diseases and published several papers in leading journals. She presents papers annually at the American College of Rheumatology, European League Against Rheumatology, and Asia Pacific League of Associations for Rheumatology.
Also consider reading:
Log in to request more information from DBAJ

Notes and media contacts

About Dubai Bone and Joint Center:

Dubai Bone and Joint Center (DBAJ) is the first and only center for musculoskeletal treatment and research in the Middle East, offering patients world-class specialists and facilities to improve their quality of life and to have a chance to live a pain free life.

DBAJ aims to operate according to international healthcare standards by offering residents and expatriates in the Middle East the highest quality and the latest innovative treatments and evidence-based medicines according to international protocols.

The center addresses various conditions ranging from children and adult spinal conditions, pelvic and acetabular fractures, reconstructive surgery, and rheumatology. It also offers total joint arthroplasty, revision total joint arthroplasty, limb lengthening and limb deformity correction, infective non-union surgery, foot deformities, neuromuscular disorders, and sports medicine.

DBAJ is a committed associate of the government's efforts to develop Dubai into a 'Center of Medical Excellence' for the region. It is a member of Dubai Healthcare City.

For further information, kindly contact:

Farah Ibrahim
TRACCS
Tel: +9714 3672530
Fax: +9714 3672531

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions